Insights On Trial Design
-
Overview Of Bladder Cancer: Global Clinical Trials Landscape
11/15/2024
Advances in immunotherapy, targeted drugs, and clinical trials are improving outcomes for bladder cancer patients, addressing regional disparities and accessibility challenges worldwide.
-
Human-Centered RTSM Design Enhances Data, Safety, And Operations
12/5/2025
Uncover how this human-centered approach to RTSM prioritizes user experience (UX) and interface design (UI) to reduce complexity, minimize errors, and improve compliance.
-
ICH E6(R3): 10 FAQ On What Changed And What It Means For Your Trials
9/18/2025
The ICH E6(R3) updated guidelines present 10 critical changes to make clinical trials more efficient, adaptable, and patient-centric, while upholding the standards of scientific and ethical integrity.
-
Critical Imaging Risks In GLP-1 And Neurology Studies
5/27/2025
As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.
-
Liver Cancer — Global Clinical Trial Landscape (2024)
7/3/2024
Explore the latest advancements and clinical trial landscape in liver cancer research with Novotech CRO's comprehensive disease report.
-
How To Improve Patient Outcomes Using eSource Software In Clinical Trials
8/11/2025
As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.
-
Rethinking Recruitment: Patient-Centric Strategies For The Future Of Clinical Trials
9/30/2025
For sponsors and CROs, the message is clear: recruitment must be redesigned for accessibility, inclusivity, and patient trust.
-
One Key To Choosing The Best eClinical Technology Vendor
2/29/2024
Explore why the integration of etechnologies is critical in the modernization and optimization of clinical trials, and how the right partner will ensure studies are more efficient, reliable, and inclusive.
-
Critical Imaging Risks In GLP-1 And Neurology Studies
4/3/2025
In the evolving landscape of GLP-1 and neurology clinical trials, imaging has become a pivotal tool for evaluating both efficacy and safety. Delve into the early indicators of imaging-related challenges and insights into preclinical strategies for effective risk mitigation.
-
A New Blueprint For Transforming Feasibility And Recruitment
9/22/2025
Discover how a connected approach links feasibility and recruitment, using real-world data to design realistic protocols, reach the right patients, and accelerate enrollment with confidence.